Table 2.
Cardiac tumors (n = 24) | Cardiac thrombi (n = 19) | P value (tumors vs. thrombi) | |||||
---|---|---|---|---|---|---|---|
Lymphoma (n = 4) | Metastasis (n = 5) | Myxoma (n = 9) | Other* (n = 6) | All (n = 24) | |||
Volume (cm3) | 32.14 ± 8.77 | 36.50 ± 7.84 | 24.24 ± 5.84 | 9.89 ± 7.16 | 24.52 ± 3.76 | 3.98 ± 4.22 | <0.001 |
CT attenuation value (HU) | 94.63 ± 21.11 | 88.60 ± 18.88 | 74.11 ± 14.08 | 44.02 ± 17.24 | 73.03 ± 8.78 | 74.50 ± 9.87 | 0.912 |
Iodine concentration (mg/mL) | 3.04 ± 0.58 | 2.96 ± 0.52 | 3.33 ± 0.39 | 2.43 ± 0.47 | 2.98 ± 0.23 | 1.79 ± 0.26 | 0.002 |
SI ratio† | 4.13 ± 2.76 | 3.31 ± 3.39 | 10.30 ± 1.95 | 5.92 ± 2.14 | 6.90 ± 0.12 | 1.43 ± 0.14 | 0.008 |
Note: Estimated mean ± SE (standard error) by the mixed effects model.
*Other tumor included cavernous hemangioma (n = 2), lipoma (n = 2), angiofibroma (n = 1), and papillary fibroelastoma (n = 1).
†For SI ratio, sample size was 16 for cardiac tumors and 12 for cardiac thrombi.
HU, Hounsfield units; SI, signal intensity.